{"id":2564,"date":"2025-01-23T22:26:59","date_gmt":"2025-01-23T19:26:59","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2564"},"modified":"2025-03-07T14:53:34","modified_gmt":"2025-03-07T11:53:34","slug":"belief-biomed-announces-ind-clearance-by-fda-for-duchenne-muscular-dystrophy-gene-therapy-candidate-bbm-d101","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/fr\/belief-biomed-announces-ind-clearance-by-fda-for-duchenne-muscular-dystrophy-gene-therapy-candidate-bbm-d101\/","title":{"rendered":"Belief BioMed annonce l&#039;autorisation de l&#039;IND par FDA pour le candidat-th\u00e9rapie g\u00e9nique contre la dystrophie musculaire de Duchenne BBM-D101"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Belief BioMed annonce l&#039;autorisation de l&#039;IND FDA pour le candidat \u00e0 la th\u00e9rapie g\u00e9nique BBM-D101 pour la dystrophie musculaire de Duchenne.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La Food and Drug Administration (FDA) des \u00c9tats-Unis a approuv\u00e9 une demande d&#039;IND (Investigational New Drug) pour le candidat de th\u00e9rapie g\u00e9nique pour la dystrophie musculaire de Duchenne (DMD) de Belief BioMed (BBM), BBM-D101. BBM est une soci\u00e9t\u00e9 de biotechnologie avant-gardiste qui se concentre sur la cr\u00e9ation de th\u00e9rapies g\u00e9niques innovantes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L&#039;objectif de cette \u00e9tude clinique ouverte \u00e0 dose unique \u00e9tait d&#039;\u00e9valuer la s\u00e9curit\u00e9 et l&#039;efficacit\u00e9 d&#039;une perfusion intraveineuse unique chez des patients atteints de DMD \u00e2g\u00e9s de 4 \u00e0 9 ans. En raison de sa capside modifi\u00e9e, BBM-D101 est plus efficace pour transduire le tissu musculaire. Par cons\u00e9quent, BBM-D101 devrait avoir une bonne s\u00e9curit\u00e9 et la dose clinique sugg\u00e9r\u00e9e est inf\u00e9rieure \u00e0 celle des produits de th\u00e9rapie g\u00e9nique \u00e0 base de virus ad\u00e9no-associ\u00e9s (AAV) comparables autoris\u00e9s.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Apprendre encore plus:<\/strong>\u00a0<a href=\"https:\/\/dmdwarrior.com\/fr\/new-gene-therapies-for-duchenne-muscular-dystrophy\/\" target=\"_blank\" rel=\"noreferrer noopener\">Nouvelles th\u00e9rapies g\u00e9niques potentielles \u00e0 venir pour la dystrophie musculaire de Duchenne<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Belief BioMed Reports FDA IND Clearance for Gene Therapy Candidate BBM-D101 for Duchenne Muscular Dystrophy. The U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for Belief BioMed&#8217;s (BBM) Duchenne Muscular Dystrophy (DMD) gene therapy candidate, BBM-D101. BBM is a forward-thinking biotechnology company that focuses on creating innovative gene therapies. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2565,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[199,197,123,66,61,198],"class_list":["post-2564","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-bbm-d101","tag-belief-biomed","tag-china","tag-duchenne-muscular-dystrophy","tag-gene-therapy","tag-shanghai"],"subtitle":"Belief BioMed annonce l'autorisation de l'IND FDA pour le candidat \u00e0 la th\u00e9rapie g\u00e9nique BBM-D101 pour la dystrophie musculaire de Duchenne.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=2564"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/2565"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=2564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=2564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=2564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}